Award Overview
Abbvie Sp. z o.o. was awarded Poland – Antineoplastic agents – Dostawa produktów leczniczych - Mirvetuximabum Soravtansinum by Centrum Onkologii im. Franciszka Łukaszczyka w Bydgoszczy in Poland, tracked by GlobalGov. The award is valued at $10.6M. It was awarded on April 29, 2026. Classification: NAICS 33652100. Full award details and the issuing agency are below.
See who is winning government contracts in this market — and the open opportunities coming next. Track awards, incumbents, and recompetes worldwide. Free for 14 days, no card.
Start FreeAward Details
| Awardee | Abbvie Sp. z o.o. |
|---|---|
| Awardee country | Poland |
| Awarding agency | Centrum Onkologii im. Franciszka Łukaszczyka w Bydgoszczy |
| Country | Poland |
| Award value | $10.6M |
| Award date | April 29, 2026 |
| NAICS | 33652100 |
| Official source | View original award record |
| Last verified | September 1, 2026 |
Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.
Track every Poland contract award and the opportunities behind them. Free for 14 days.
Get incumbent intelligence, recompete alerts, and deadline tracking for this market and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required